Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMM...

by Alessandro Soria, Daria Trabattoni, Nicola Squillace, Veronica Rainone, Federica Gnudi, Mario Clerici, Andrea Gori, Alessandra Bandera, Alessandra Bandera
Published 2015-01-01

miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir

by Elena Bresciani, Cecilia Saletti, Nicola Squillace, Laura Rizzi, Laura Molteni, Ramona Meanti, Robert J. Omeljaniuk, Giuseppe Biagini, Andrea Gori, Vittorio Locatelli, Antonio Torsello
Published 2019-04-01

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery

by Alessandra Bandera, Michela Masetti, Michela Masetti, Massimiliano Fabbiani, Mara Biasin, Antonio Muscatello, Nicola Squillace, Mario Clerici, Mario Clerici, Andrea Gori, Andrea Gori, Daria Trabattoni
Published 2018-02-01

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

by Paolo Maggi, Antonio Di Biagio, Stefano Rusconi, Stefania Cicalini, Maurizio D’Abbraccio, Gabriella d’Ettorre, Canio Martinelli, Giuseppe Nunnari, Laura Sighinolfi, Vincenzo Spagnuolo, Nicola Squillace
Published 2017-08-01

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observa...

by Lucia Taramasso, Paola Tatarelli, Elena Ricci, Giordano Madeddu, Barbara Menzaghi, Nicola Squillace, Giuseppe Vittorio De Socio, Canio Martinelli, Roberto Gulminetti, Paolo Maggi, Giancarlo Orofino, Francesca Vichi, Antonio Di Biagio, Paolo Bonfanti, on behalf of CISAI Study Group
Published 2018-07-01

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

by Giuseppe Vittorio De Socio, Marta Pasqualini, Elena Ricci, Paolo Maggi, Giancarlo Orofino, Nicola Squillace, Barbara Menzaghi, Giordano Madeddu, Lucia Taramasso, Daniela Francisci, Paolo Bonfanti, Francesca Vichi, Marco dell’Omo, Luca Pieroni, On behalf of CISAI study group
Published 2020-05-01

Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)

by Lucia Taramasso, Elena Ricci, Antonio Cascio, Laura Valsecchi, Barbara Menzaghi, Nicola Squillace, Paolo Maggi, Giuseppe Vittorio De Socio, Chiara Dentone, Giordano Madeddu, Giovanni F. Pellicanò, Leonardo Calza, Goffredo Angioni, Paolo Bonfanti, Antonio Di Biagio, CISAI Study Group
Published 2019-08-01

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study

by Paolo Maggi, Carmen R. Santoro, Marco Nofri, Elena Ricci, Nicolò De Gennaro, Chiara Bellacosa, Elisabetta Schiaroli, Giancarlo Orofino, Barbara Menzaghi, Antonio Di Biagio, Nicola Squillace, Daniela Francisci, Francesca Vichi, Chiara Molteni, Paolo Bonfanti, Giovanni Battista Gaeta, Giuseppe Vittorio De Socio
Published 2019-06-01

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovir...

by Nicola Squillace, Elena Ricci, Tiziana Quirino, Andrea Gori, Alessandra Bandera, Laura Carenzi, Giuseppe Vittorio De Socio, Giancarlo Orofino, Canio Martinelli, Giordano Madeddu, Stefano Rusconi, Paolo Maggi, Benedetto Maurizio Celesia, Laura Cordier, Francesca Vichi, Leonardo Calza, Katia Falasca, Antonio Di Biagio, Giovanni Francesco Pellicanò, Paolo Bonfanti, CISAI Study Group
Published 2017-01-01

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospe...

by Antonio Muscatello, Silvia Nozza, Massimiliano Fabbiani, Ilaria De Benedetto, Marco Ripa, Raffaele Dell’Acqua, Andrea Antinori, Carmela Pinnetti, Andrea Calcagno, Micol Ferrara, Emanuele Focà, Eugenia Quiros-Roldan, Diego Ripamonti, Marco Campus, Benedetto Maurizio Celesia, Carlo Torti, Lucio Cosco, Antonio Di Biagio, Stefano Rusconi, Giulia Marchetti, Cristina Mussini, Roberto Gulminetti, Antonella Cingolani, Gabriella D’Ettorre, Giordano Madeddu, Antonina Franco, Giancarlo Orofino, Nicola Squillace, Andrea Gori, Giuseppe Tambussi, Alessandra Bandera
Published 2020-02-01

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

by Francesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, Carlo Salvarani, Roberto Parrella, Anna Maria Marata, Patrizia Popoli, Laurenzia Ferraris, Massimiliano M. Marrocco-Trischitta, Diego Ripamonti, Francesca Binda, Paolo Bonfanti, Nicola Squillace, Francesco Castelli, Maria Lorenza Muiesan, Miriam Lichtner, Carlo Calzetti, Nicola Duccio Salerno, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Cosimo Facciolongo, Fiorentino Fraganza, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Gerardo Botti, Claudia Cardone, Piera Gargiulo, Adriano Gravina, Clorinda Schettino, Laura Arenare, Paolo Chiodini, Ciro Gallo, the TOCIVID-19 investigators, Italy
Published 2020-10-01